Addressing Canada's Pharmaceutical Research and Development Intensity Gap: The Role of Health Data Transformation.

Mullie T, Chuck A.

Open source

DOI
10.12927/hcq.2026.27906
Published
2026-07-01
Container
Healthc Q
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.12927/hcq.2026.27906,
  title = {Addressing Canada's Pharmaceutical Research and Development Intensity Gap: The Role of Health Data Transformation.},
  author = {Mullie T and  Chuck A.},
  year = {2026},
  journal = {Healthc Q},
  doi = {10.12927/hcq.2026.27906},
  url = {https://doi.org/10.12927/hcq.2026.27906}
}

RIS

TY  - JOUR
TI  - Addressing Canada's Pharmaceutical Research and Development Intensity Gap: The Role of Health Data Transformation.
AU  - Mullie T
AU  -  Chuck A.
PY  - 2026
JO  - Healthc Q
DO  - 10.12927/hcq.2026.27906
UR  - https://doi.org/10.12927/hcq.2026.27906
ER  - 

APA

T, M., & A., C. (2026). Addressing Canada's Pharmaceutical Research and Development Intensity Gap: The Role of Health Data Transformation.. Healthc Q. https://doi.org/10.12927/hcq.2026.27906

Source records